Vnitřní lékařství 5/2020

PŘEHLEDOVÉ ČLÁNKY Katetrizační implantace aortální chlopně – co víme v roce 2020 286 | VNITŘNÍ LÉKAŘSTVÍ / Vnitř Lék 2020; 66(5): 282–286 /  www.casopisvnitrnilekarstvi.cz LITERATURA 1. Durko AP, Osnabrugge RL, Van Mieghem NM, et al. Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projec- tions. Eur Heart J 2018; 39: 2635–2642. 2. Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease preva- lence and number of candidates for transcatheter aortic valve replacement: a meta-ana- lysis and modeling study. J Am Coll Cardiol 2013; 62: 1002–1012. 3. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulati- on 2002; 106: 3006–3008. 4. Cahill TJ, Chen M, Hayashida K, et al. Transcatheter aortic valve implantation: current status and future perspectives. Eur Heart J 2018; 39: 2625–2634. 5. Abdel-Wahab M, Mehilli J, Frerker C, et al. Comparison of balloon-expandable vs self- -expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 2014; 311: 1503–1514. 6. Adams DH, Popma JJ, Reardon MJ et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014; 370: 1790–1798. 7. Gerckens U, Tamburino C, Bleiziffer S et al. Final 5-year clinical and echocardiographic results for treatment of severe aortic stenosis with a self-expanding bioprosthesis from the ADVANCE Study. Eur Heart J 2017; 38: 2729–2738. 8. Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgi- cal aortic-valve replacement. N Engl J Med 2012; 366: 1686–1695. 9. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2016; 374: 1609–1620. 10. Wendler O, Schymik G, Treede H, et al. SOURCE 3: 1-year outcomes post-transcathe- ter aortic valve implantation using the latest generation of the balloon-expandable tran- scatheter heart valve. Eur Heart J 2017; 38: 2717–2726. 11. Manoharan G, Van Mieghem NM, Windecker S et al. 1-Year Outcomes With the Evo- lut R Self-Expanding Transcatheter Aortic Valve: From the International FORWARD Study. JACC Cardiovasc Interv 2018; 11: 2326–2334. 12. Attizzani GF, Patel SM, Dangas GD, et al. Comparison of Local Versus General Anesthe- sia Following Transfemoral Transcatheter Self-Expanding Aortic Valve Implantation (from the Transcatheter Valve Therapeutics Registry). Am J Cardiol 2019; 123: 419–425. 13. Biancari F, Rosato S, D’Errigo P, et al. Immediate and Intermediate Outcome After Transapical Versus Transfemoral Transcatheter Aortic Valve Replacement. Am J Cardiol 2016; 117: 245–251. 14. Cocchieri R, Petzina R, Romano M, et al. Outcomes after transaortic transcatheter aor- tic valve implantation: long-term findings from the European ROUTE. Eur J Cardiothorac Surg 2019; 55: 737–743 15. Wood DA, Lauck SB, Cairns JA, et al. The Vancouver 3M (Multidisciplinary, Multimoda- lity, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Cen- ters: The 3M TAVR Study. JACC Cardiovasc Interv 2019; 12: 459–469. 16. Walther T, Hamm CW, Schuler G, et al. Perioperative Results and Complications in 15,964 Transcatheter Aortic Valve Replacements: Prospective Data From the GARY Registry. J Am Coll Cardiol 2015; 65: 2173–2180. 17. Ludman PF. UK TAVI registry. Heart 2019; 105: (Suppl. 2): s2–s5. 18. Gaede L, Blumenstein J, Liebetrau C, et al. Outcome after transvascular transcatheter aortic valve implantation in 2016. Eur Heart J 2018; 39: 667–675. 19. Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve re- placement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015; 385: 2477–2484. 20. Chakos A, Wilson-Smith A, Arora S, et al. Long term outcomes of transcatheter aortic valve implantation (TAVI): a systematic review of 5-year survival and beyond. Ann Cardio- thorac Surg 2017; 6: 432–443. 21. Gleason TG, Reardon MD, Popma JJ, et al. 5-Year Outcomes of Self-Expanding Tran- scatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients. J Am Coll Car- diol 2018; 72: 2687–2696. 22. Thyregod HGH, Ihlemann N, Jorgensen TH, et al. Five-Year Clinical and Echocardiogra- phic Outcomes from the Nordic Aortic Valve Intervention (NOTION) Randomized Clinical Trial in Lower Surgical Risk Patients. Circulation 2019. E pub ahead of print. 23. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38: 2739–2791. 24. Deeb GM, Chetcuti SJ, Reardon MJ, et al. 1-Year Results in Patients Undergoing Tran- scatheter Aortic Valve Replacement With Failed Surgical Bioprostheses. JACC Cardiovasc Interv 2017; 10: 1034–1044. 25. Webb JG, Mack MJ, White JM, et al. Transcatheter Aortic Valve Implantation Within Degenerated Aortic Surgical Bioprostheses: PARTNER 2 Valve-in-Valve Registry. J Am Coll Cardiol 2017; 69: 2253–2262. 26. Yoon SH, Whisenant BK, Bleiziffer S, et al. Outcomes of transcatheter mitral valve re- placement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J 2019; 40: 441–451. 27. Sondergaard L, Ihlemann N, Capodanno D, et al., Durability of Transcatheter and Sur- gical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk. J Am Coll Cardiol 2019; 73: 546–553. 28. Sulzenko J, Tousek P, Kocka V, et al. Transcatheter aortic valve implantation: long-term clinical outcome and valve durability. Expert Rev Med Devices 2015; 12: 529–535. 29. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replace- ment in high-risk patients. N Engl J Med 2011; 364: 2187–2198. 30. Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med 2017; 376: 1321–1331. 31. Nijenhuis VJ, Brouwer J, Delewi R, et al. Anticoagulation with or without Clopi- dogrel after Transcatheter Aortic-Valve Implantation. N Engl J Med. 2020 Apr 30; 382(18): 1696–1707. Léčebné konopí v současné medicínské praxi Landa Leoš, Juřica Jan, kolektiv Léčebné použití konopí představuje mimořádně diskutovanou problematiku. Kniha zmiňuje konkrétní lékové formy konopí, hlavní indikační oblasti, je doplněna vhodnými kazuistikami a nezapomíná ani na oblast veterinární medicíny. Grada Publishing, a. s., U Průhonu 22, 170 00 Praha 7, tel.: 220 386 511, 512, 603/26 20 18, fax: 220 386 400, www.grada.cz ISBN: 978-80-247-3967-0 KNIŽNÍ NOVINKA